DE69721040D1 - Als antioxydanten verwendbare substituierte phenole und thiophenole - Google Patents

Als antioxydanten verwendbare substituierte phenole und thiophenole

Info

Publication number
DE69721040D1
DE69721040D1 DE69721040T DE69721040T DE69721040D1 DE 69721040 D1 DE69721040 D1 DE 69721040D1 DE 69721040 T DE69721040 T DE 69721040T DE 69721040 T DE69721040 T DE 69721040T DE 69721040 D1 DE69721040 D1 DE 69721040D1
Authority
DE
Germany
Prior art keywords
antioxydants
thiophenols
substituted phenols
phenols
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721040T
Other languages
English (en)
Other versions
DE69721040T2 (de
Inventor
A Parker
S Wright
J Busch
S Chen
T-Building Yates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69721040D1 publication Critical patent/DE69721040D1/de
Application granted granted Critical
Publication of DE69721040T2 publication Critical patent/DE69721040T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
DE69721040T 1996-11-20 1997-10-07 Als antioxydanten verwendbare substituierte phenole und thiophenole Expired - Lifetime DE69721040T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75552896A 1996-11-20 1996-11-20
PCT/US1997/018055 WO1998022418A1 (en) 1996-11-20 1997-10-07 Substituted phenols and thiophenols useful as antioxidant agents

Publications (2)

Publication Number Publication Date
DE69721040D1 true DE69721040D1 (de) 2003-05-22
DE69721040T2 DE69721040T2 (de) 2003-10-16

Family

ID=25039544

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721040T Expired - Lifetime DE69721040T2 (de) 1996-11-20 1997-10-07 Als antioxydanten verwendbare substituierte phenole und thiophenole

Country Status (22)

Country Link
EP (1) EP0942896B1 (de)
JP (2) JP4267705B2 (de)
KR (2) KR100698995B1 (de)
CN (1) CN1168693C (de)
AR (1) AR009429A1 (de)
AT (1) ATE237574T1 (de)
AU (1) AU734050B2 (de)
BR (1) BR9713372A (de)
CA (1) CA2271054C (de)
DE (1) DE69721040T2 (de)
DK (1) DK0942896T3 (de)
ES (1) ES2191828T3 (de)
HK (1) HK1021970A1 (de)
HU (1) HUP9904244A3 (de)
IL (1) IL129957A (de)
NO (1) NO318039B1 (de)
NZ (1) NZ335440A (de)
PT (1) PT942896E (de)
SI (1) SI0942896T1 (de)
TW (1) TW508349B (de)
WO (1) WO1998022418A1 (de)
ZA (1) ZA9710315B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
EP1695959A1 (de) * 1997-05-14 2006-08-30 Atherogenics, Inc. Verbindungen und Methoden zur Hemmung der VCAM-1 Expression
PL194329B1 (pl) * 1997-05-14 2007-05-31 Atherogenics Inc Zastosowanie monoestru probukolu kwasu bursztynowego lub jego farmaceutycznie dopuszczalnej soli dowytwarzania leku do leczenia choroby, której mediatorem jest VCAM-1
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
AU2002363318B2 (en) * 2001-10-25 2008-09-11 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US20070260087A1 (en) 2004-04-20 2007-11-08 Atherogenics, Inc. Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
KR100725582B1 (ko) 2004-06-29 2007-06-08 주식회사 동부하이텍 식물병원균의 생장억제활성을 갖는 알킬페놀 유도체
MX2007007453A (es) * 2004-12-22 2007-07-19 Ciba Sc Holding Ag Agentes antirradicales.
WO2008118948A1 (en) 2007-03-26 2008-10-02 Atherogenics, Inc. Methods and compositions of derivatives of probucol for the treatment of diabetes
KR101420083B1 (ko) * 2012-04-04 2014-07-15 이화여자대학교 산학협력단 Ｕｃｈ－ｌ１ 저해 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 ｕｃｈ－ｌ１ 관련 질환의 예방 또는 치료용 약학적 조성물
WO2014185561A1 (ko) * 2013-05-13 2014-11-20 이화여자대학교 산학협력단 신규한 화합물 또는 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 ｕｃｈ－ｌ１ 관련 질환의 예방 또는 치료용 약학적 조성물
WO2016170704A1 (ja) * 2015-04-23 2016-10-27 株式会社日本ハイポックス 慢性呼吸器疾患治療剤及び心臓の線維化抑制組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57176038A (en) * 1981-04-21 1982-10-29 Fuji Photo Film Co Ltd Silver halide color photographic material
CA2050514A1 (en) * 1990-09-14 1992-03-15 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
DE4109627A1 (de) * 1991-03-23 1992-09-24 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
CA2096496A1 (en) * 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
EP0589069B1 (de) * 1992-09-18 1997-01-29 Nippon Hypox Laboratories Incorporated Hydrochinonderivate und diese enthaltende Antioxydantien sowie Tumorinhibitoren
JP3050733B2 (ja) * 1992-10-16 2000-06-12 中外製薬株式会社 ４−アルコキシ−２，６−ジ−ｔ−ブチルフェノール誘導体
TW393475B (en) * 1992-10-16 2000-06-11 Chugai Pharmaceutical Co Ltd 4-alkoxyl-2,6-di-t-butyl phenol derivatives

Also Published As

Publication number Publication date
AU734050B2 (en) 2001-05-31
SI0942896T1 (en) 2003-08-31
HK1021970A1 (en) 2000-07-21
KR100648118B1 (ko) 2006-11-28
CA2271054A1 (en) 1998-05-28
CA2271054C (en) 2005-12-13
NO992390L (no) 1999-07-16
TW508349B (en) 2002-11-01
NO318039B1 (no) 2005-01-24
DK0942896T3 (da) 2003-07-28
CN1168693C (zh) 2004-09-29
AR009429A1 (es) 2000-04-12
KR20060016839A (ko) 2006-02-22
KR20000057135A (ko) 2000-09-15
CN1237955A (zh) 1999-12-08
IL129957A0 (en) 2000-02-29
HUP9904244A3 (en) 2002-07-29
KR100698995B1 (ko) 2007-03-26
EP0942896B1 (de) 2003-04-16
BR9713372A (pt) 2000-03-21
ZA9710315B (en) 1998-05-20
JP2001504483A (ja) 2001-04-03
NZ335440A (en) 2001-07-27
JP4267705B2 (ja) 2009-05-27
ES2191828T3 (es) 2003-09-16
IL129957A (en) 2005-06-19
JP2009132710A (ja) 2009-06-18
ATE237574T1 (de) 2003-05-15
AU4809897A (en) 1998-06-10
PT942896E (pt) 2003-07-31
EP0942896A1 (de) 1999-09-22
NO992390D0 (no) 1999-05-19
HUP9904244A2 (hu) 2000-09-28
DE69721040T2 (de) 2003-10-16
WO1998022418A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
DE60008677D1 (de) Kieselsäureplättchen und diese enthaltende härtbare Zusammensetzung
DE69913128D1 (de) Teilweise blockverschachtelte cdma-kodierung und dekodierung
DE69940166D1 (de) Feinteilige acrylpolymere und diese enthaltende plastisole
DE19983141T1 (de) Vernetzbare Zusammensetzung und daraus erhältlicher vernetzter Gegenstand
DE60032247D1 (de) Fluorchemisches oligomer und seine verwendung
DE69736582D1 (de) Uv-härtbare klebstoffzusammensetzung und gegenstand
DE69723398T2 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
DE69721040T2 (de) Als antioxydanten verwendbare substituierte phenole und thiophenole
FR2749777B1 (fr) Composition photocatalytique transparente inorganique
DE69931799D1 (de) Absorptionsbeschleuniger und diese enthaltende zubereitungen zur transdermalen absorption
DE60004658D1 (de) Thiazolidindionderivat und seine verwendung als antidiabetikum
DE69919549D1 (de) Sauerstoffabsorbierende zusammensetzung und ihre anwendungsmethode
DE69724367D1 (de) Polyarylensulfid und zusammensetzung
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
ID18154A (id) Amplop dapat digunakan kembali yang mudah dibuka
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
ID16838A (id) Komposisi dekafluoropentana
DE69613393D1 (de) Behandelte kohlenstoffartige zusammensetzungen und verbesserte polymerzusammensetzungen
DE69809658T2 (de) Verwendung eines Ionenleiters zur Verbesserung der Photochromie und diesen enthaltende Zusammensetzung
DE69732095D1 (de) Ionomerzusammensetzung und ihre verwendung
ID17419A (id) Komposisi dekafluoropentana
HK1042089A1 (zh) 氮雜環縮肽及其作為殺寄生蟲劑的用途
DE69704008D1 (de) Lagerfähige, stabile und vernetzbare Siliconzusammensetzung
ATE235498T1 (de) Alkyl-4-silylheterocyclische phenole und thiophenole als antioxidansmittel
DE59706998D1 (de) Strahlungshärtende zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US